These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7144728

  • 1. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B, Gorissen H, Laduron PM.
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [Abstract] [Full Text] [Related]

  • 2. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 3. Solubilization of serotonin S2-receptors from human brain.
    Schotte A, Maloteaux JM, Laduron PM.
    Eur J Pharmacol; 1984 May 04; 100(3-4):329-33. PubMed ID: 6734724
    [Abstract] [Full Text] [Related]

  • 4. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE.
    J Physiol (Paris); 1981 May 04; 77(2-3):351-62. PubMed ID: 7288650
    [Abstract] [Full Text] [Related]

  • 5. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
    De Souza EB.
    Endocrinology; 1986 Oct 04; 119(4):1534-42. PubMed ID: 2944737
    [Abstract] [Full Text] [Related]

  • 6. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PA.
    J Pharmacol Exp Ther; 1988 Jan 04; 244(1):310-21. PubMed ID: 3336007
    [Abstract] [Full Text] [Related]

  • 7. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K, Sato M, Kashihara K, Otsuki S.
    Biol Psychiatry; 1982 Dec 04; 17(12):1389-402. PubMed ID: 7159638
    [Abstract] [Full Text] [Related]

  • 8. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
    Paulose CS, Dakshinamurti K.
    J Neurosci Res; 1985 Dec 04; 14(2):263-70. PubMed ID: 4046074
    [Abstract] [Full Text] [Related]

  • 9. [Effect of in vitro serotonin on dopaminergic binding sites in rat striatal membranes].
    Oelssner W, Raubach KH, Oelssner W.
    Biomed Biochim Acta; 1983 Dec 04; 42(7-8):931-6. PubMed ID: 6651809
    [Abstract] [Full Text] [Related]

  • 10. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 04; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 11. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM, Janssen PF, Leysen JE.
    Eur J Pharmacol; 1982 Jun 16; 81(1):43-8. PubMed ID: 7117369
    [Abstract] [Full Text] [Related]

  • 12. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec 16; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 13. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
    Nelson DL, Pedigo NW, Yamamura HI.
    J Physiol (Paris); 1981 Dec 16; 77(2-3):369-72. PubMed ID: 7288652
    [Abstract] [Full Text] [Related]

  • 14. Solubilization and characterization of active opiate binding sites from mammalian brain.
    Howells RD, Gioannini TL, Hiller JM, Simon EJ.
    J Pharmacol Exp Ther; 1982 Sep 16; 222(3):629-34. PubMed ID: 6286927
    [Abstract] [Full Text] [Related]

  • 15. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
    Kendall DA, Nahorski SR.
    J Pharmacol Exp Ther; 1983 Nov 16; 227(2):429-34. PubMed ID: 6631722
    [Abstract] [Full Text] [Related]

  • 16. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PA.
    Psychopharmacology (Berl); 1986 Nov 16; 88(4):434-44. PubMed ID: 3010361
    [Abstract] [Full Text] [Related]

  • 17. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.
    Maloteaux JM.
    Acta Neurol Belg; 1986 Nov 16; 86(2):61-129. PubMed ID: 2873704
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V.
    J Neural Transm Suppl; 1983 Nov 16; 18():165-79. PubMed ID: 6192208
    [Abstract] [Full Text] [Related]

  • 19. Characterization of cholate-solubilized dopamine receptors from human, dog and rat brain.
    Wouters W, van Dun J, Laduron PM.
    Biochem Pharmacol; 1984 Dec 15; 33(24):4039-44. PubMed ID: 6508850
    [Abstract] [Full Text] [Related]

  • 20. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E, Breeding M.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):169-73. PubMed ID: 3139864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.